Alpine Global Management, LLC Acelrx Pharmaceuticals Inc Transaction History

Alpine Global Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$1.03 - $1.7 $13,866 - $22,887	13,463 New	13,463 $19,000
Q2 2019 Jul 12, 2019	SELL	$2.1 - $3.93 $71,248 - $133,337	-33,928 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$2.35 - $3.83 $26,515 - $43,213	-11,283 Reduced 24.96%	33,928 $118,000
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $96,299 - $217,012	45,211 New	45,211 $104,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.